MSC Advertisement
Pharma Focus Asia
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

07

May 2021

ITM Establishes Subsidiary in Shanghai to Accelerate Introduction of Its Precision Oncology Portfolio in China

ITM AG a leading radiopharmaceutical company today announced the establishment of a Chinese subsidiary ITM Shanghai Precision Medical Co Ltd in Shanghai China The new subsidiary will be part of the ITM Group as a wholly foreignowned entity WFOE to further expand ITMs growing operations in China whic...

07

May 2021

Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer

Genprex Inc a clinicalstage gene therapy company focused on developing lifechanging technologies for patients with cancer and diabetes today announced that the Company and a major cancer research center in Houston Texas in March entered into an amendment the Amendment to their May License Agreemen...

06

May 2021

Esker Therapeutics Launches to Transform the Treatment of Autoimmune Diseases

Esker Therapeutics a Foresite Labsincubated precision medicine company that is reimagining the discovery development and treatment of autoimmune disorders launched today with a million Series A financing from Foresite Capital Esker plans to address the limitations of currently available treatments...

06

May 2021

CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings

Crown Bioscience a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs has acquired OcellO BV a privately owned contract research organization located in the Netherlands Through the acquisition CrownBio will expa...

press releasesRead more...

07

May 2021

China NMPA Approves PARP Inhibitor Pamiparib for Patients with Previously Treated Advanced Ovarian Cancer

BeiGene Ltd a global biotechnology company focused on developing and commercializing innovative medicines worldwide today announced that its PARP inhibitor pamiparib has received conditional approval from the China National Medical Products Administration NMPA for the treatment of patients with germ...

06

May 2021

Roche’s Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer

Roche announced that the European Commission has approved Tecentriq atezolizumab as a firstline initial treatment for adults with metastatic nonsmall cell lung cancer NSCLC whose tumours have high PDL expression with no epidermal growth factor receptor EGFR or anaplastic lymphoma kinase ALK genomic...

06

May 2021

Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum’s Novel Preclinical Candidate Targeting Woman’s Gynecological Conditions

Aptorum Group Limited a clinicalstage biopharmaceutical company has entered into an agreement with Exeltis Exeltis a division of the global pharmaceutical group Insud Pharma to develop manufacture and commercialize a novel preclinical candidate from Aptorum in the following territories the European...

06

May 2021

Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research

Sanofi has entered into a threeyear research collaboration with Stanford University School of Medicine Together the two organizations and their scientists will work to advance the understanding of immunology and inflammation through open scientific exchange Additionally Sanofi will provide funding a...

EventsRead more...

07 - 08

May 2021

Materials Science and Materials Chemistry

Prague

10 - 11

May 2021

Cancer Science and Cancer Therapy

Munich

10 - 11

May 2021

Highly Potent Active Pharmaceutical Ingredients

SMi Group
Virtual

10 - 11

May 2021

21st Annual Pain Therapeutic 2021

online

Rousselot - X-Pure® GelMA
Meco - 90 years
Medical Fair Thailand 2021
analytica Vietnam 2021

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of Singapore

  • Articles

    3D Printing Revolutionising Nanotechnology

    Threedimensional D printing is a prototyping method which works through layerbylayer fabrication making rapid conversion of instruction from digital D diagrams into physical objects It is a manufacturing method in which objects or any machinery are made by fusing or depositing any materials in layersbylayersmethod to produce a D object

  • Research Insights

    Zika Virus Replicons For Drug Discovery

    Abstract The current epidemic of Zika virus ZIKV has underscored the urgency to establish experimental systems for studying viral replication and pathogenesis and countermeasure development Here we report two ZIKV replicon systems a luciferase replicon that can differentiate between viral translation and RNA synthesis and a stable luciferase replicon carr

  • Techno Trends

    Pfizer Launches Janus Kinase 3 (JAK3) Inhibitor PF-06651600

    Pfizer launched its investigational oral Janus Kinase JAK inhibitor PF which is used for the treatment of patients with alopecia areata Alopecia areata is chronic autoimmune skin disease in which immune cells attack healthy hair follicles causing hair loss in round patches and causes hair loss on the scalp face or body The mean age for the diseases onset is bet...

  • White Papers

    NextGen Pharma Takes ‘Smart’ Strides with Internet of Things

    Abstract Digitization of processes and data across the value chain along with the emergence of Internet of Things IoT has transformed the Pharma industry Although IoT is still in the nascent stage of adoption in the Life Sciences industry the use of smart devices and machinetomachine MM communication leveraging SMAC technologies comes at a time when

Advisory Board

Stella Stergiopoulos

Stella
Sanjoy Ray

Sanjoy Ray
Rustom Mody

Rustom
Phil Kaminsky

Phil
Neil J Campbell

Neil J
Laurence Flint

Laurence
Kenneth I Kaitin

Kenneth I
Georg C Terstappen

Georg C
Frank A Jaeger

Frank A
Douglas Meyer

Douglas
Christopher-Paul Milne

Christopher-
Alan S Louie

Alan S Louie

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...